CORMEDIX INC (CRMD) Forecast, Price Target & Analyst Ratings
NASDAQ:CRMD • US21900C3088
6.69 USD
-0.03 (-0.45%)
At close: Mar 11, 2026
6.69 USD
0 (0%)
After Hours: 3/11/2026, 8:00:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORMEDIX INC (CRMD).
Forecast Snapshot
Consensus Price Target
$15.15
+ 126.52% Upside
Next Earnings Forecast
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate$0.54
Revenue Estimate107.08M
ChartMill Buy Consensus
83.08%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$15.15
Upside
+ 126.52%
From current price of $6.69 to mean target of $15.15, Based on 13 analyst forecasts
Low
$13.13
Median
$15.30
High
$18.90
Price Target Revisions
1 Month
-7.97%
3 Months
-21.80%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for CRMD. The average price target is 15.15 USD. This implies a price increase of 126.52% is expected in the next year compared to the current price of 6.69.
The average price target has been revised downward by 21.8% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.08%
CRMD was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRMD.
In the previous month the buy percentage consensus was at a similar level.
CRMD was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Needham | Maintains | Buy -> Buy |
| 2026-02-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-08 | Needham | Maintains | Buy -> Buy |
| 2025-12-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-12 | Needham | Maintains | Buy -> Buy |
| 2025-10-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | D. Boral Capital | Upgrade | Hold -> Buy |
| 2025-09-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-30 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-06-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-06-24 | Needham | Maintains | Buy -> Buy |
| 2025-06-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
| 2025-05-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-26 | Needham | Maintains | Buy -> Buy |
| 2025-03-26 | RBC Capital | Reiterate | Outperform -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate$0.54
Revenue Estimate107.08M
Revenue Q2Q173.99%
EPS Q2Q78.45%
Number of Analysts9
Next Earnings Revisions
Revenue (1 Month)
-1.60%
Revenue (3 Months)
-0.39%
EPS (1 Month)
-2.39%
EPS (3 Months)
0.78%
Next Earnings Summary
CRMD is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.54 USD and the consensus revenue estimate is 107.08M USD.
The next earnings revenue estimate has been revised downward by 0.39% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 70K -63.16% | -100.00% | 43.472M | 316.32M 627.64% | 315.14M -0.37% | 291.53M -7.49% | 481.45M 65.15% | 433.54M -9.95% | 563.9M 30.07% | 714.25M 26.66% | 802.7M 12.38% | 931.4M 16.03% | |
| EBITDA YoY % growth | -30.54M -3.95% | -48.887M -60.08% | -22.047M 54.90% | 201.09M 1,012.11% | 125.12M -37.78% | 106.61M -14.79% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30.62M -4.01% | -48.958M -59.89% | -22.356M 54.34% | 167.02M 847.08% | 117.73M -29.51% | 103.35M -12.21% | 245.27M 137.32% | 193.92M -20.94% | 305.61M 57.60% | 436.3M 42.76% | 511.12M 17.15% | 616.5M 20.62% | |
| Operating Margin | -43,742.86% | N/A | -51.43% | 52.80% | 37.36% | 35.45% | 50.94% | 44.73% | 54.20% | 61.09% | 63.68% | 66.19% | |
| EPS YoY % growth | -0.74 | -0.92 -24.32% | -0.33 64.13% | 2.73 712.12% | 1.36 -32.63% | 1.08 -20.74% | 3.06 183.69% | 1.93 -37.00% | 3.93 103.70% | 4.52 15.06% | 5.04 11.51% | 5.76 14.37% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.54 78.45% | 0.56 99.36% | 0.14 -88.94% | 0.54 200.33% |
| Revenue Q2Q % growth | 107.08M 173.99% | 99.588M 150.62% | 56.284M -46.02% | 114.04M -11.33% |
| EBITDA Q2Q % growth | 55.77M 174.90% | 45.726M 130.14% | 14.384M -74.06% | 60.445M -25.29% |
| EBIT Q2Q % growth | 52.852M 162.61% | 48.402M 147.66% | 13.633M -73.45% | 51.678M -27.69% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.85%
EPS Next 5 Year
14.22%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
15.03%
Revenue Next 5 Year
12.26%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
83.07%
EBIT Next 5 Year
N/A
CORMEDIX INC / CRMD Forecast FAQ
What is the price target for CRMD stock?
13 analysts have analysed CRMD and the average price target is 15.15 USD. This implies a price increase of 126.52% is expected in the next year compared to the current price of 6.69.
What is the next earnings date for CRMD stock?
CORMEDIX INC (CRMD) will report earnings on 2026-05-04.
Can you provide the consensus estimates for CORMEDIX INC next earnings?
The consensus EPS estimate for the next earnings of CORMEDIX INC (CRMD) is 0.54 USD and the consensus revenue estimate is 107.08M USD.
Can you provide the analyst count for CORMEDIX INC stock?
The number of analysts covering CORMEDIX INC (CRMD) is 13.